Poster: AML-157: Economic Burden of Hospitalizations for Acute Myeloid Leukemia (AML) in Remission in the United States: A Retrospective Analysis of an Administrative Claims Database

2021 ◽  
Vol 21 ◽  
pp. S212
Author(s):  
Clara Chen ◽  
Eros Papademetriou ◽  
Xing Liu ◽  
Ravi Potluri
2018 ◽  
Vol 71 ◽  
pp. 27-33 ◽  
Author(s):  
Jill A. Bell ◽  
Aaron Galaznik ◽  
Eileen Farrelly ◽  
Marlo Blazer ◽  
Sharanya Murty ◽  
...  

2020 ◽  
Vol 20 ◽  
pp. S181
Author(s):  
Ashley Tabah ◽  
David Huggar ◽  
Brenna L. Brady ◽  
Krutika Jariwala-Parikh ◽  
Krystal Huey ◽  
...  

2019 ◽  
Vol 35 (5) ◽  
pp. 927-935 ◽  
Author(s):  
Bruno C. Medeiros ◽  
Bhavik J. Pandya ◽  
Anna Hadfield ◽  
James Pike ◽  
Samuel Wilson ◽  
...  

2018 ◽  
Vol 2 (11) ◽  
pp. 1277-1282 ◽  
Author(s):  
Vijaya Raj Bhatt ◽  
Valerie Shostrom ◽  
Krishna Gundabolu ◽  
James O. Armitage

Key Points An analysis of 61 775 adults with AML diagnosed between 2003 and 2011 demonstrated that 25% did not receive any chemotherapy. Factors such as facility type, patients’ race, income, and insurance status were associated with the rates of use of chemotherapy.


2015 ◽  
Vol 94 (7) ◽  
pp. 1127-1138 ◽  
Author(s):  
Bruno C. Medeiros ◽  
Sacha Satram-Hoang ◽  
Deborah Hurst ◽  
Khang Q. Hoang ◽  
Faiyaz Momin ◽  
...  

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e18516-e18516
Author(s):  
Peter G Kim ◽  
Tao Zou ◽  
Andrew Mark Brunner ◽  
Ashley M. Perry ◽  
Kristin L McGregor ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document